health · HHS-NIH11
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
National Institutes of Health · RFA-CA-27-016
Total Program Funding
$11.8M
Expected Awards
6
Deadline
June 30, 2026
GRANTQUICK SUMMARYPlain-English Overview
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required). National Institutes of Health. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain or establish Lead Academic Organizations (LAOs) as part of the NCI Experimental Therapeutics Clinical Trials Network (ETCTN). ETCTN... $11,800,000 total program funding; ~6 awards expected.
Who Should Apply
Other eligible entities, State governments, Other Native American Tribal Organizations, Independent school districts, For-profit organizations (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Refer to Section III
- •Deadline: 2026-06-30
💡 GrantQuick Tip
High-value award — invest significantly in proposal quality. Consider hiring a grant writer.
Competitiveness: High — limited number of awards
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Total Program Funding
- $11.8M
- Expected Number of Awards
- 6
- Cost Sharing Required?
- No
- Funding Instrument
- cooperative_agreement
Key Dates
Agency Contact
NCI ETCTN RFA Email: NCIETCTNRFA@mail.nih.gov
Email: NCIETCTNRFA@mail.nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov